Nevertheless, in several cancers including basal cell carcinoma (BCC) and medulloblastoma (MB), HH pathway is constitutively activated and related to ligand-independent mechanism, due to somatic mutations in PTCH1, SMO or SUFU genes [9]. This evidence concerns the gene SMO and basal cell carcinoma.